They need regulatory approval above all things. Multi center study not needed to get regulatory approval especially for a start up. Don’t care about advincula, more interested in regulatory approval.

So why do a multi-center study when it cost much more and all they need to do is prove safety and efficacy for regulatory approval. What start up company does that?

Maybe they aren't paying for the multi centered study - its not accounted for in the financials. They will need more money (raise, warrant money) to cover the cost of it.

OR

JnJ/Medtronic (or any biggun) is controlling the multi center study.



Would probably be easy to figure out - just see what companies are currently hiring individuals to do clinical trials in robotic surgery at world renown facilities.

Why are you telling me its more cost, I know its more cost - tell your boy SPORT19 its more cost - he was looking for one reason.

They need more people, clinical people. They need to have 5 fully functioning SPORT Platforms, resources.

Cost, expense, time, resources, personnel and on and on. I didn't even have to think to come up with more than one reason (wonder how much time you had to think to NOT EVEN come up with one reason).

Titan only has 5 employees, what do you want Randall at Nicholson center collecting clinical data on SPORT for regulatory. All they have to do is prove safety and efficacy for regulatory approval.

JnJ/Titan/Verb/Auris

The more I thought about it really the only companies that would want multi-center studies prior to regulatory clearance would be companies like JNJ,Medtronic,etc the big boys bc they don’t just want Regulatory clearance but also studies to integrate the newly approved product into their sales/distribution process. I’ve never seen a start up company like Titan seeking regulatory approval do a multi center study.

Why in the world would a start up company like Titan be doing a multi center study? They don’t need that for regulatory approval. I find it fascinating that Titan is doing multi centered studies. It is such a big company move when they bring a product to
Market not a startups.

SPORT19 knows squat

Go ask Randall, he will tell u

As the shorters work this to get it to your $2.50 prediction, once it gets there and they do the raise it will be a very good time to buy. You have predicted it to get to $2.50 and the raise will come at that price so I am fully expecting this to be worked back to $2.50

Pretty certain that the shorters will work this down tomorrow to help cover ....i would not be surprised if PPS falls big time tomorrow and the next two days.

Saw TRXC's Vice President of Sales left the company.

Obviously Titan has introduced a whole new camera (flexible endoscope), has anyone dug into the camera yet? Not too many companies making top of the line endoscopes for robotic surgery

You don't know??? Wow, for someone that tries to portray he knows something but doesn't know why Scott H stepped down.....keep digging and I am sure if you put the work in, you will find it...maybe.

remember when you told people just a month ago to sell at $1.20 and take the tax loss - then they can buy in January at 70 cents. Of course, they lost over 70% of their shares by taking that advice - just being real. Not really interested in advice from someone who is not invested in this stock.

Titan could easily announce buyout at Design Freeze, very possible. With even a little warrant money they will have enough to get to design freeze (it's pretty much done already).

All they need is a well timed PR on Monday to get this shooting up - hopefully they can shake Bernholz and his cronies.

Believe me, he already knows that.

Like I said, shorts getting hammered.

Still some ways to go on this BUT it is great to see the shorts getting hammered. They continue to try and work this stock back to cover but can’t get it. Each new day the stock opens higher and they spend all day trying to get it back but Titan isn’t what it was when bernholz and his cronies had field days with it.

Welcome to 2016 when most of us knew this bit of info.

wrong

No, I am saying that those that advised others to sell their shares in December and then they can buy back into Titan in January at 50-70 cents per share which would mean they would have even more shares were wrong, in fact those that followed that advice at this point would own 72% less shares then they did in December.

But to your point, if they didn't sell, those 10,000 shares at $4.27 are worth $42,700, compared to 2,810 shares worth $12,000 at $4.27 so yes it would be a better financial position

Just some more interesting info:

If someone had sold their 10,000 shares at $1.20 to take the tax loss in December (as some suggested), they would have $12,000 to invest.

If they took that $12,000 and bought today at $4.27, they would have 2,810 shares - a loss of 7,190 shares or 72% less shares.

Sure was nice to see the shorts get hammered over the last month

JnJ/Titan/Verb/Auris

Really??? You are saying that they should do another raise rather than push to get warrants exercised, that is something a non-investor would say. Amazing, considering your posts in the past begging the company to get pps up to get warrants exercised.

Not surprising, I guess, considering your advice to take the tax loss at the end of 2018 and buy back in at 70 cents in January 2019.

Out of sheer curiosity, what story are you referring too?

Makes up for the tech

Warrant money coming in

Interesting notes:

If a Titan investor had listened to some on December and sold their 10,000 shares to take the tax loss at $1.20. They would have $12,000. If they waited their 30 days to avoid a wash sale and took that $12,000 and bought in today at $3.20 - they would only have 3,750 shares - they would have just over a 1/3 of the shares they once owned b/c they sold. When it goes to $4/share - when they buy back in they only have 2,500 shares. I remember some saying to sell, sell, sell and buy back in in January and they can get it for 50-80 cents a share.

Imagine that going from about 10,000 shares to only having 3,750 - when we get to a market cap of $200M then those 10,000 shares are worth $95,000 and those 3,750 shares are worth $35,700.

How about this, at close today:

Titan Medical Inc - TMDI - $2.80
Transenterix - TRXC - $2.73

It is absolutely clear that right the better investment is TMDI for anyone getting into investing in surgical robotics. TRXC has been going down with FDA APPROVED product and TMDI has been going up.

speaking of a company's board members:

https://www.markets.co/a-director-at-transenterix-inc-nyse-trxc-is-selling-shares/179336/

Correction to this: It won't be the next quarterly report as that will cover up to 12/31/2018. I will want to review the following that will cover the quarter from 1/1/2019 to 3/31/2019 (which would be expected Mid-May 2019)

So on the warrants, I put that out there as something that I will look for in Titan's next public quarterly report. If they release the report and their cash on hand goes up without a raise then warrants will have been exercised seems like a logical explanation

Interestingly Honey777 could provide the board a more accurate guesstimation of cash on hand expected next quarter end without any raise. I am not up to date on burn rate, current cash on hand, current shares outstanding. I would imagine that cash on hand and current shares outstanding would go up if warrants were excercised this quarter in relation to burn rate and no raise. Would that be right?

Just something that investors will want to look into when Titan releases their next quarterly report.

It could be that warrants were exercised based off milestone achievement of engineering confidence build.

Based off of the Warrant listing on the Titan webiste:

https://titanmedicalinc.com/wp-content/uploads/2018/09/TITAN-MEDICAL-INC-Warrants-August-2018.pdf

It says there are 6,222,285 warrants outstanding - so if they all get excercised that means total shares is 27,922,285. Also, if those warrants get excercised the proceeds from that is $114 MILLION. It will be interesting if they continue to support PPS to raise money from warrants rather than do another offering. Their history suggest offering but the obviously have enough money available in warrants

Well make sure when you want to quote what i Believe you get it right and say:

JnJ/Titan/Verb

BC utilizing the Sales/Marketing/Distribution might of JNJ and operating on the VERB Software platform is VERY, VERY SPECIAL.

Now I am done with you and putting you ignore.

I don't question everyone's investing method or reason, I just am pointing out those on this board who are flat out wrong. For example, the whole VERB thing, you and some of the others think they are a robotic company and will only "partner" with one company. That is completely short sighted and fact is that they have already "partnered" with Getinge. And when I say that Titan will utilize VERB's software in their platform, you and your cohorts say "Well how can they then partner with another company" - again just shortsighted. The Titan SPORT Platform will run off of VERB software and be marketed/distributed/Sold thru the JNJ sales/marketing channel - that is why i have invested. (all based off the info I shared about what JNJ Innovations role is in developing companies like Titan).

As for having fun at my expense, have at it. We have fun at your expense right now so it will not bother me one bit whether you do or don't. When I think about what the naysayers say on this board, it gives me great comfort that what i know is more on target compared to the naysayers.

Good info though.

Wrong article, this one is from 2016. More recent article

obviously you are just starting to realize that too..... you to are welcome to the party... one you wrap your mind around it, you will start to understand what is going on.

TRXC is a POS that is worth $500M

So you are saying that you are just realizing that...... well welcome to the party pal